The authors analyzed 326 samples and concluded that adding p16 IHC led to more accurate stratification of CIN lesions, with fewer CIN 1/2 cases and more “no CIN” or CIN 3 cases, thereby avoiding overtreatment [48]. The gene discussed is CDKN2A; the disease is cervical squamous intraepithelial neoplasia.